BG
DVAX

Bellevue Group’s Dynavax Technologies DVAX Stock Holding History

Bellevue Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,558
Closed -$309K – 169
2024
Q2 		$309K Hold
27,558
– – 0.01% 139
2024
Q1 		$342K Sell
27,558
-15,642
-36% -$204K 0.01% 142
2023
Q4 		$604K Sell
43,200
-40,000
-48% -$556K 0.01% 132
2023
Q3 		$1.23M Buy
+83,200
New +$1.17M 0.02% 122
2018
Q3 		– Sell
-91,800
Closed -$1.4M – 142
2018
Q2 		$1.4M Sell
91,800
-2,700
-3% -$46.7K 0.12% 106
2018
Q1 		$1.88M Buy
94,500
+39,500
+72% +$682K 0.19% 84
2017
Q4 		$1.03M Sell
55,000
-4,500
-8% -$90.3K 0.11% 110
2017
Q3 		$1.28M Buy
+59,500
New +$941K 0.13% 103

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bellevue Group's DVAX Position: Q3 2024 in Review

Bellevue Group sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 27,558 shares — an estimated $309K sold.

Bellevue Group first reported a position in DVAX in Q3 2017 and held it in 8 quarters. The position peaked at $1.88M in Q1 2018. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Bellevue Group reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Bellevue Group sold 27,558 Dynavax Technologies shares in Q3 2024, an estimated $309K.
  • Bellevue Group first reported a position in Dynavax Technologies in Q3 2017 and held it in 8 quarters.
  • Bellevue Group's Dynavax Technologies position peaked at $1.88M in Q1 2018.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Bellevue Group's 13F filing for Q3 2024, filed 14 Nov 2024.